[1] G. Peat, R. McCarney, P. Croft, Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care, ANN RHEUM DIS, 60 (2001) 91–7.
[2] L. Michou, Genetics of digital osteoarthritis, JOINT BONE SPINE, 78 (2011) 347–51.
[3] Z. C. Tong, Y. Liu, B. Chen, L. Yan, D. J. Hao, Association between MMP3 and TIMP3 polymorphisms and risk of osteoarthritis, ONCOTARGET, 8 (2017) 83563–83569.
[4] S. Honsawek, S. Malila, P. Yuktanandana, A. Tanavalee, B. Deepaisarnsakul, J. Parvizi, Association of MMP–3 (–1612 5A/6A) polymorphism with knee osteoarthritis in Thai population, RHEUMATOL INT, 33 (2013) 435–439.
[5] W. Guo, P. Xu, T. Jin, J. Wang, D. Fan, Z. Hao, Y. Ji, S. Jing, C. Han, Du J, D. Jiang, S. Wen, J. Wang, MMP–3 gene polymorphisms are associated with increased risk of osteoarthritis in Chinese men, Oncotarget, 8 (2017) 79491–79497.
[6] G. Murphy, H. Nagase, Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol, 4 (2008) 128–35.
[7] A. Kaspiris, L. Khaldi, T. B. Grivas, E. Vasiliadis, I. Kouvaras, S. Dagkas, E. Chronopoulos, E. Papadimitriou, Subchondral cyst development and MMP–1 expression during progression of osteoarthritis: an immunohistochemical study, Orthop Traumatol Surg Res, 99 (2013) 523–9.
[8] P. S. Burrage, K. S. Mix, C. E. Brinckerhoff, Matrix metalloproteinases: role in arthritis, Front Biosci, 11 (2006) 529–43.
[9] J. L. Rutter, T. I. Mitchell, G. Buttice, J. Meyers, J. F. Gusella, L. J. Ozelius, C. E. Brinckerhoff, A single nucleotide polymorphism in the matrix metalloproteinase–1 promoter creates an Ets binding site and augments transcription, CANCER RES, 58 (1998) 5321–5.
[10] M. P. Vincenti, C. E. Brinckerhoff, Transcriptional regulation of collagenase (MMP–1, MMP–13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors, Arthritis Res, 4 (2002) 157–64.
[11] R. Geng, Y. Xu, W. Hu, H. Zhao, The association between MMP–1 gene rs1799750 polymorphism and knee osteoarthritis risk, BIOSCIENCE REP, 38 (2018) BSR20181257.
[12] J. L. Rutter, T. I. Mitchell, G. Buttice, J. Meyers, J. F. Gusella, L. J. Ozelius, C. E. Brinckerhoff, A single nucleotide polymorphism in the matrix metalloproteinase–1 promoter creates an Ets binding site and augments transcription, CANCER RES, 58 (1998) 5321–5.
[13] I.Ö. Barlas, M. Sezgin, M. E. Erdal, G. Sahin, H. C. Ankarali, Z. M. Altintas, E. Türkmen, Association of (−1,607) 1G/2G polymorphism of matrix metalloproteinase–1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms), RHEUMATOL INT, 29 (2009) 383–388.
[14] H. Y. Yang, S. Y. Chuang, W. H. Fang, G. S. Huang, C. C. Wang, Y. Y. Huang, M. Y. Chu, C. Lin, W. Su, C. Y. Chen, Y. T. Yang, S. L. Su, Effect of RAGE polymorphisms on susceptibility to and severity of osteoarthritis in a Han Chinese population: a case-control study, Genetics and Molecular Research, 14 (2015) 11362–11370.
[15] P. Lepetsos, A. Pampanos, E. Kanavakis, M. Tzetis, D. Korres, A. G. Papavassiliou, N. Efstathopoulos, Association ofMMP–1–1607 1G/2G (rs1799750) polymorphism with primary knee osteoarthritis in the Greek population, J ORTHOP RES, 32 (2014) 1155–1160.
[16] S. H. Abd-Allah, S. M. Shalaby, H. F. Pasha, A. S. El-Shal, A.M. Abou El-Saoud, Variation of Matrix Metalloproteinase 1 and 3 Haplotypes and Their Serum Levels in Patients with Rheumatoid Arthritis and Osteoarthritis, GENET TEST MOL BIOMA, 16 (2012) 15–20.
[17] N. MANTEL, W. HAENSZEL, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22 (1959) 719–48.
[18] R. DerSimonian, N. Laird, Meta-analysis in clinical trials revisited, CONTEMP CLIN TRIALS, 45 (2015) 139–45.
[19] M. Egger, S. G. Davey, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315 (1997) 629–34.
[20] F. Capsoni, A.M. Ongari, C. Lonati, R. Accetta, S. Gatti, A. Catania, alpha-Melanocyte-stimulating-hormone (alpha-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines, BMC Musculoskelet Disord, 16 (2015) 154.
[21] M. H. Moon, J. K. Jeong, Y. J. Lee, J. W. Seol, C. J. Jackson, S. Y. Park, SIRT1, a class III histone deacetylase, regulates TNF-alpha-induced inflammation in human chondrocytes, Osteoarthritis Cartilage, 21 (2013) 470–80.
[22] T. L. Huang, C. H. Yang, G. Yanai, J. Y. Liao, S. Sumi, K. C. Yang, Synergistic effect of l-ascorbic acid and hyaluronic acid on the expressions of matrix metalloproteinase–3 and –9 in human chondrocytes, J Biomed Mater Res B Appl Biomater, 106 (2018) 1809–1817.
[23] H. Q. Hao, J. F. Zhang, Q. Q. He, Z. Wang, Catirlage oligomeric matrix protein, C-terminal cross-linking telopeptide of type II collagen, and matrix metalloproteinase–3 as biomarkers for knee and hip osteoarthritis (OA) diagnosis: a systematic review and meta-analysis, Osteoarthritis Cartilage, (2018).
[24] Y. Wan, W. Li, Z. Liao, M. Yan, X. Chen, Z. Tang, Selective MMP–13 inhibitors: promising agents for the therapy of Osteoarthritis, CURR MED CHEM, (2018).
[25] R. Nakagawa, R. Akagi, S. Yamaguchi, T. Enomoto, Y. Sato, S. Kimura, Y. Ogawa, A. Sadamasu, S. Ohtori, T. Sasho, Single vs. repeated matrix metalloproteinase–13 knockdown with intra-articular short interfering RNA administration in a murine osteoarthritis model, CONNECT TISSUE RES, (2018) 1–9.
[26] L. C. Tetlow, D. J. Adlam, D. E. Woolley, Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes, Arthritis Rheum, 44 (2001) 585–94.
[27] P. Xu, J. Wang, Z. Hao, Review Acticle The polymorphism of rs1799750 in matrix metallopeptidase 1 (MMP–1) gene contributes to osteoarthritis risk: a meta-analysis, INT J CLIN EXP MED, 10 (2016) 18824–18833.